content

Merck and Transylvanian Institute of Neuroscience Cooperate on Brain-Inspired Artificial Intelligence

Merck, a leading science and technology company,ย  announced a three-year collaboration with the Transylvanian Institute of Neuroscience (TINS), based in Cluj-Napoca, Romania. The primary...

Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...

Merck to Manufacture Next-Generation Biotherapeutics for Alteogen

Merck, a leading science and technology company, announced an agreement with Alteogen, Inc., of South Korea, providing late-stage CDMO services through Merckโ€™s BioRelianceยฎ End-to-End...

UCB and Microsoft Expand Collaboration to Accelerate Drug Discovery and Development

UCB and Microsoft have announced a new multi-year, strategic collaboration to combine Microsoftโ€™s computational services, cloud, and artificial intelligence (AI) with UCBโ€™s drug discovery...

Egyptian Drug Authority approves Sputnik V vaccine for emergency use

The Egyptian Drug Authority has approved the Russian Direct Investment Fundโ€™s (RDIF) Covid-19 vaccine, Sputnik V, under the emergency use authorisation (EUA) procedure. The Egyptian...

C2 PHARMA Completes Multiple Regulatory Filings, Expands API Portfolio to Solidify Position as a Leading Ophthalmic API Supplier to the Pharmaceutical Industry

C2 PHARMA, a pharmaceutical group established in 2014 focused on niche active pharmaceutical ingredient (APIs), has expanded its portfolio of APIs and botanical extracts...

Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones

The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read